1.
Rheumatol Int
; 32(12): 4061-3, 2012 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-21922339
RESUMEN
A patient with chronic inflammatory demyelinating polyradiculoneuropathy and systemic lupus erythematosus arising after rubella vaccination was initially treated with plasmapheresis, corticosteroids and intravenous immunoglobulins, with partial response. After shift to rituximab, most clinical symptoms improved markedly, emphasizing the possible role of this monoclonal antibody in conventional therapy-resistant cases.